Invariant NKT Cells: Regulation and Function during Viral Infection

English version České info

Natural killer T cells (NKT cells) represent a subset of T lymphocytes that express natural killer (NK) cell surface markers. A subset of NKT cells, termed invariant NKT cells (iNKT), express a highly restricted T cell receptor (TCR) and respond to CD1d-restricted lipid ligands. iNKT cells are now appreciated to play an important role in linking innate and adaptive immune responses and have been implicated in infectious disease, allergy, asthma, autoimmunity, and tumor surveillance. Advances in iNKT identification and purification have allowed for the detailed study of iNKT activity in both humans and mice during a variety of chronic and acute infections. Comparison of iNKT function between non-pathogenic simian immunodeficiency virus (SIV) infection models and chronic HIV-infected patients implies a role for iNKT activity in controlling immune activation. In vitro studies of influenza infection have revealed novel effector functions of iNKT cells including IL-22 production and modulation of myeloid-derived suppressor cells, but ex vivo characterization of human iNKT cells during influenza infection are lacking. Similarly, as recent evidence suggests iNKT involvement in dengue virus pathogenesis, iNKT cells may modulate responses to a number of emerging pathogens. This Review will summarize current knowledge of iNKT involvement in responses to viral infections in both human and mouse models and will identify critical gaps in knowledge and opportunities for future study. We will also highlight recent efforts to harness iNKT ligands as vaccine adjuvants capable of improving vaccination-induced cellular immune responses.

Vyšlo v časopise: Invariant NKT Cells: Regulation and Function during Viral Infection. PLoS Pathog 8(8): e32767. doi:10.1371/journal.ppat.1002838
Kategorie: Review
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002838

Souhrn

Zdroje

1. BrossayL, ChiodaM, BurdinN, KoezukaY, CasoratiG, et al. (1998) CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med 188: 1521–1528.

2. WunKS, BorgNA, Kjer-NielsenL, BeddoeT, KohR, et al. (2008) A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR. J Exp Med 205: 939–949.

3. CouedelC, PeyratMA, BrossayL, KoezukaY, PorcelliSA, et al. (1998) Diverse CD1d-restricted reactivity patterns of human T cells bearing “invariant” AV24BV11 TCR. Eur J Immunol 28: 4391–4397.

4. KashiwaseK, KikuchiA, AndoY, NicolA, PorcelliSA, et al. (2003) The CD1d natural killer T-cell antigen presentation pathway is highly conserved between humans and rhesus macaques. Immunogenetics 54: 776–781.

5. PorcelliSA, ModlinRL (1999) The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol 17: 297–329.

6. MatsudaJL, GapinL, FazilleauN, WarrenK, NaidenkoOV, et al. (2001) Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor beta repertoire and small clone size. Proc Natl Acad Sci U S A 98: 12636–12641.

7. DianaJ, LehuenA (2009) NKT cells: friend or foe during viral infections? Eur J Immunol 39: 3283–3291.

8. HuT, GimferrerI, Alberola-IlaJ (2011) Control of early stages in invariant natural killer T-cell development. Immunology 134: 1–7.

9. ChunT, PageMJ, GapinL, MatsudaJL, XuH, et al. (2003) CD1d-expressing dendritic cells but not thymic epithelial cells can mediate negative selection of NKT cells. J Exp Med 197: 907–918.

10. PellicciDG, UldrichAP, KyparissoudisK, CroweNY, BrooksAG, et al. (2003) Intrathymic NKT cell development is blocked by the presence of alpha-galactosylceramide. Eur J Immunol 33: 1816–1823.

11. GordyLE, BezbradicaJS, FlyakAI, SpencerCT, DunkleA, et al. (2011) IL-15 Regulates Homeostasis and Terminal Maturation of NKT Cells. J Immunol 187: 6335–6345.

12. BezmanNA, ChakrabortyT, BenderT, LanierLL (2011) miR-150 regulates the development of NK and iNKT cells. J Exp Med 208: 2717–2731.

13. ZhengQ, ZhouL, MiQS (2012) MicroRNA miR-150 Is Involved in Valpha14 Invariant NKT Cell Development and Function. J Immunol 188: 2118–2126.

14. BrennanPJ, TatituriRV, BriglM, KimEY, TuliA, et al. (2011) Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals. Nat Immunol 12: 1202–1211.

15. BurrowsPD, KronenbergM, TaniguchiM (2009) NKT cells turn ten. Nat Immunol 10: 669–671.

16. KawakamiK, YamamotoN, KinjoY, MiyagiK, NakasoneC, et al. (2003) Critical role of Valpha14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection. Eur J Immunol 33: 3322–3330.

17. KinjoY, IllarionovP, VelaJL, PeiB, GirardiE, et al. (2011) Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nat Immunol 12: 966–974.

18. MattnerJ, SavagePB, LeungP, OerteltSS, WangV, et al. (2008) Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe 3: 304–315.

19. KinjoY, TupinE, WuD, FujioM, Garcia-NavarroR, et al. (2006) Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 7: 978–986.

20. KumarH, BelperronA, BartholdSW, BockenstedtLK (2000) Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi. J Immunol 165: 4797–4801.

21. TupinE, BenhniaMR, KinjoY, PatseyR, LenaCJ, et al. (2008) NKT cells prevent chronic joint inflammation after infection with Borrelia burgdorferi. Proc Natl Acad Sci U S A 105: 19863–19868.

22. BriglM, BrennerMB (2010) How invariant natural killer T cells respond to infection by recognizing microbial or endogenous lipid antigens. Semin Immunol 22: 79–86.

23. FischerK, ScotetE, NiemeyerM, KoebernickH, ZerrahnJ, et al. (2004) Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc Natl Acad Sci U S A 101: 10685–10690.

24. KinjoY, WuD, KimG, XingGW, PolesMA, et al. (2005) Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434: 520–525.

25. WuD, XingGW, PolesMA, HorowitzA, KinjoY, et al. (2005) Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proc Natl Acad Sci U S A 102: 1351–1356.

26. MattnerJ, DebordKL, IsmailN, GoffRD, CantuC3rd, et al. (2005) Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525–529.

27. GrantEP, DeganoM, RosatJP, StengerS, ModlinRL, et al. (1999) Molecular recognition of lipid antigens by T cell receptors. J Exp Med 189: 195–205.

28. MatsudaJL, MallevaeyT, Scott-BrowneJ, GapinL (2008) CD1d-restricted iNKT cells, the ‘Swiss-Army knife’ of the immune system. Curr Opin Immunol 20: 358–368.

29. GodfreyDI, RossjohnJ (2011) New ways to turn on NKT cells. J Exp Med 208: 1121–1125.

30. LeePT, BenlaghaK, TeytonL, BendelacA (2002) Distinct functional lineages of human V(alpha)24 natural killer T cells. J Exp Med 195: 637–641.

31. BendelacA, SavagePB, TeytonL (2007) The biology of NKT cells. Annu Rev Immunol 25: 297–336.

32. KoguchiY, BuenafeAC, ThaulandTJ, GardellJL, Bivins-SmithER, et al. (2012) Preformed CD40L is stored in Th1, Th2, Th17, and T follicular helper cells as well as CD48 thymocytes and invariant NKT cells but not in Treg cells. PLoS ONE 7: e31296 doi:10.1371/journal.pone.0031296.

33. PeiB, VelaJL, ZajoncD, KronenbergM (2012) Interplay between carbohydrate and lipid in recognition of glycolipid antigens by natural killer T cells. Ann N Y Acad Sci 1253: 68–79.

34. BriglM, BryL, KentSC, GumperzJE, BrennerMB (2003) Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol 4: 1230–1237.

35. PagetC, MallevaeyT, SpeakAO, TorresD, FontaineJ, et al. (2007) Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 27: 597–609.

36. RafteryMJ, WinauF, GieseT, KaufmannSH, SchaibleUE, et al. (2008) Viral danger signals control CD1d de novo synthesis and NKT cell activation. Eur J Immunol 38: 668–679.

37. BriglM, TatituriRV, WattsGF, BhowruthV, LeadbetterEA, et al. (2011) Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection. J Exp Med 208: 1163–1177.

38. NagarajanNA, KronenbergM (2007) Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J Immunol 178: 2706–2713.

39. WangX, BishopKA, HegdeS, RodenkirchLA, PikeJW, et al. (2012) Human invariant natural killer T cells acquire transient innate responsiveness via histone H4 acetylation induced by weak TCR stimulation. J Exp Med 209: 987–1000.

40. TakahashiT, ChibaS, NiedaM, AzumaT, IshiharaS, et al. (2002) Cutting edge: analysis of human V alpha 24+CD8+ NK T cells activated by alpha-galactosylceramide-pulsed monocyte-derived dendritic cells. J Immunol 168: 3140–3144.

41. IshiharaS, NiedaM, KitayamaJ, OsadaT, YabeT, et al. (1999) CD8(+)NKR-P1A (+)T cells preferentially accumulate in human liver. Eur J Immunol 29: 2406–2413.

42. KimCH, ButcherEC, JohnstonB (2002) Distinct subsets of human Valpha24-invariant NKT cells: cytokine responses and chemokine receptor expression. Trends Immunol 23: 516–519.

43. MotsingerA, HaasDW, StanicAK, Van KaerL, JoyceS, et al. (2002) CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection. J Exp Med 195: 869–879.

44. D'AndreaA, GouxD, De LallaC, KoezukaY, MontagnaD, et al. (2000) Neonatal invariant Valpha24+ NKT lymphocytes are activated memory cells. Eur J Immunol 30: 1544–1550.

45. SandbergJK, FastNM, PalaciosEH, FennellyG, DobroszyckiJ, et al. (2002) Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection. J Virol 76: 7528–7534.

46. BaevDV, PengXH, SongL, BarnhartJR, CrooksGM, et al. (2004) Distinct homeostatic requirements of CD4+ and CD4− subsets of Valpha24-invariant natural killer T cells in humans. Blood 104: 4150–4156.

47. ChenX, WangX, BesraGS, GumperzJE (2007) Modulation of CD1d-restricted NKT cell responses by CD4. J Leukoc Biol 82: 1455–1465.

48. ThedrezA, de LallaC, AllainS, ZaccagninoL, SidobreS, et al. (2007) CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells. Blood 110: 251–258.

49. TessmerMS, FatimaA, PagetC, TrotteinF, BrossayL (2009) NKT cell immune responses to viral infection. Expert Opin Ther Targets 13: 153–162.

50. ChangYJ, HuangJR, TsaiYC, HungJT, WuD, et al. (2007) Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids. Proc Natl Acad Sci U S A 104: 10299–10304.

51. GumperzJE, MiyakeS, YamamuraT, BrennerMB (2002) Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med 195: 625–636.

52. TakahashiT, NiedaM, KoezukaY, NicolA, PorcelliSA, et al. (2000) Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells. J Immunol 164: 4458–4464.

53. CarnaudC, LeeD, DonnarsO, ParkSH, BeavisA, et al. (1999) Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol 163: 4647–4650.

54. La CavaA, Van KaerL, Fu DongS (2006) CD4+CD25+ Tregs and NKT cells: regulators regulating regulators. Trends Immunol 27: 322–327.

55. HuaJ, LiangS, MaX, WebbTJ, PotterJP, et al. (2011) The interaction between regulatory T cells and NKT cells in the liver: a CD1d bridge links innate and adaptive immunity. PLoS ONE 6: e27038 doi:10.1371/journal.pone.0027038.

56. HermansIF, SilkJD, GileadiU, SalioM, MathewB, et al. (2003) NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J Immunol 171: 5140–5147.

57. GalliG, PittoniP, TontiE, MalzoneC, UematsuY, et al. (2007) Invariant NKT cells sustain specific B cell responses and memory. Proc Natl Acad Sci U S A 104: 3984–3989.

58. van der VlietHJ, von BlombergBM, HazenbergMD, NishiN, OttoSA, et al. (2002) Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection. J Immunol 168: 1490–1495.

59. FleuridorR, WilsonB, HouR, LandayA, KesslerH, et al. (2003) CD1d-restricted natural killer T cells are potent targets for human immunodeficiency virus infection. Immunology 108: 3–9.

60. ChiappiniE, BettiL, BonsignoriF, AzzariC, GalliL, et al. (2010) CD4(+) and CD4(−) CD1D-restricted natural killer T cells in perinatally HIV-1 infected children receiving highly active antiretroviral therapy. Int J Immunopathol Pharmacol 23: 665–669.

61. VasanS, PolesMA, HorowitzA, SiladjiEE, MarkowitzM, et al. (2007) Function of NKT cells, potential anti-HIV effector cells, are improved by beginning HAART during acute HIV-1 infection. Int Immunol 19: 943–951.

62. YangOO, WilsonSB, HultinLE, DetelsR, HultinPM, et al. (2007) Delayed reconstitution of CD4+ iNKT cells after effective HIV type 1 therapy. AIDS Res Hum Retroviruses 23: 913–922.

63. MontoyaCJ, CatanoJC, RamirezZ, RugelesMT, WilsonSB, et al. (2008) Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype. Clin Immunol 127: 1–6.

64. MollM, KuylenstiernaC, GonzalezVD, AnderssonSK, BosnjakL, et al. (2009) Severe functional impairment and elevated PD-1 expression in CD1d-restricted NKT cells retained during chronic HIV-1 infection. Eur J Immunol 39: 902–911.

65. van der VlietHJ, van VonderenMG, MollingJW, BontkesHJ, ReijmM, et al. (2006) Cutting edge: Rapid recovery of NKT cells upon institution of highly active antiretroviral therapy for HIV-1 infection. J Immunol 177: 5775–5778.

66. MollM, Snyder-CappioneJ, SpottsG, HechtFM, SandbergJK, et al. (2006) Expansion of CD1d-restricted NKT cells in patients with primary HIV-1 infection treated with interleukin-2. Blood 107: 3081–3083.

67. LiD, XuXN (2008) NKT cells in HIV-1 infection. Cell Res 18: 817–822.

68. UnutmazD (2003) NKT cells and HIV infection. Microbes Infect 5: 1041–1047.

69. NowickiMJ, VigenC, MackWJ, SeabergE, LandayA, et al. (2008) Association of cells with natural killer (NK) and NKT immunophenotype with incident cancers in HIV-infected women. AIDS Res Hum Retroviruses 24: 163–168.

70. MureithiMW, CohenK, MoodleyR, PooleD, MncubeZ, et al. (2011) Impairment of CD1d-restricted natural killer T cells in chronic HIV type 1 clade C infection. AIDS Res Hum Retroviruses 27: 501–509.

71. GleasonMK, LenvikTR, McCullarV, FelicesM, O'BrienMS, et al. (2012) Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9. Blood 119: 3064–3072.

72. NdhlovuLC, Lopez-VergesS, BarbourJD, JonesRB, JhaAR, et al. (2012) Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. Blood 119: 3734–3743.

73. FernandezCS, ChanAC, KyparissoudisK, De RoseR, GodfreyDI, et al. (2009) Peripheral NKT cells in simian immunodeficiency virus-infected macaques. J Virol 83: 1617–1624.

74. RoutN, ElseJG, YueS, ConnoleM, ExleyMA, et al. (2010) Paucity of CD4+ natural killer T (NKT) lymphocytes in sooty mangabeys is associated with lack of NKT cell depletion after SIV infection. PLoS ONE 5: e9787 doi: 10.1371/journal.pone.0009787.

75. Roelofs-HaarhuisK, WuX, GleichmannE (2004) Oral tolerance to nickel requires CD4+ invariant NKT cells for the infectious spread of tolerance and the induction of specific regulatory T cells. J Immunol 173: 1043–1050.

76. DianaJ, BrezarV, BeaudoinL, DalodM, MellorA, et al. (2011) Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay. J Exp Med 208: 729–745.

77. FavreD, LedererS, KanwarB, MaZM, ProllS, et al. (2009) Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog 5: e1000295 doi:10.1371/journal.ppat.1000295.

78. CohenGB, GandhiRT, DavisDM, MandelboimO, ChenBK, et al. (1999) The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10: 661–671.

79. ChenN, McCarthyC, DrakesmithH, LiD, CerundoloV, et al. (2006) HIV-1 down-regulates the expression of CD1d via Nef. Eur J Immunol 36: 278–286.

80. ChoS, KnoxKS, KohliLM, HeJJ, ExleyMA, et al. (2005) Impaired cell surface expression of human CD1d by the formation of an HIV-1 Nef/CD1d complex. Virology 337: 242–252.

81. AjueborMN (2007) Role of NKT cells in the digestive system. I. Invariant NKT cells and liver diseases: is there strength in numbers? Am J Physiol Gastrointest Liver Physiol 293: G651–656.

82. BendelacA, RiveraMN, ParkSH, RoarkJH (1997) Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol 15: 535–562.

83. BiburgerM, TiegsG (2005) Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells. J Immunol 175: 1540–1550.

84. ExleyMA, KozielMJ (2004) To be or not to be NKT: natural killer T cells in the liver. Hepatology 40: 1033–1040.

85. KakimiK, GuidottiLG, KoezukaY, ChisariFV (2000) Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 192: 921–930.

86. KakimiK, LaneTE, ChisariFV, GuidottiLG (2001) Cutting edge: Inhibition of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver. J Immunol 167: 6701–6705.

87. ItoH, AndoK, IshikawaT, NakayamaT, TaniguchiM, et al. (2008) Role of Valpha14+ NKT cells in the development of Hepatitis B virus-specific CTL: activation of Valpha14+ NKT cells promotes the breakage of CTL tolerance. Int Immunol 20: 869–879.

88. WoltmanAM, Ter BorgMJ, BindaRS, SprengersD, von BlombergBM, et al. (2009) Alpha-galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I/II trial. Antivir Ther 14: 809–818.

89. LiJ, HanY, JinK, WanY, WangS, et al. (2011) Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and natural killer T (NKT) cells in patients with acute hepatitis B infection. Virol J 8: 199.

90. TripathyAS, DasR, ChadhaMS, ArankalleVA (2011) Epidemic of Hepatitis B with high mortality in India: association of fulminant disease with lack of CCL4 and natural killer T cells. J Viral Hepat 18: e415–422.

91. LucasM, GadolaS, MeierU, YoungNT, HarcourtG, et al. (2003) Frequency and phenotype of circulating Valpha24/Vbeta11 double-positive natural killer T cells during hepatitis C virus infection. J Virol 77: 2251–2257.

92. DeignanT, CurryMP, DohertyDG, Golden-MasonL, VolkovY, et al. (2002) Decrease in hepatic CD56(+) T cells and V alpha 24(+) natural killer T cells in chronic hepatitis C viral infection. J Hepatol 37: 101–108.

93. van der VlietHJ, MollingJW, von BlombergBM, KolgenW, StamAG, et al. (2005) Circulating Valpha24+Vbeta11+ NKT cell numbers and dendritic cell CD1d expression in hepatitis C virus infected patients. Clin Immunol 114: 183–189.

94. InoueM, KantoT, MiyatakeH, ItoseI, MiyazakiM, et al. (2006) Enhanced ability of peripheral invariant natural killer T cells to produce IL-13 in chronic hepatitis C virus infection. J Hepatol 45: 190–196.

95. HarveyCE, PostJJ, PalladinettiP, FreemanAJ, FfrenchRA, et al. (2003) Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation. J Leukoc Biol 74: 360–369.

96. ApolinarioA, MajanoPL, Alvarez-PerezE, SaezA, LozanoC, et al. (2002) Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease. Am J Gastroenterol 97: 2861–2870.

97. de LallaC, GalliG, AldrighettiL, RomeoR, MarianiM, et al. (2004) Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis. J Immunol 173: 1417–1425.

98. WangH, ParkO, GaoB (2011) NKT cells in liver fibrosis: Controversies or complexities. J Hepatol 55: 1166.

99. IshikawaS, IkejimaK, YamagataH, AoyamaT, KonK, et al. (2011) CD1d-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in mice. J Hepatol 54: 1195–1204.

100. JinZ, SunR, WeiH, GaoX, ChenY, et al. (2011) Accelerated liver fibrosis in hepatitis B virus transgenic mice: involvement of natural killer T cells. Hepatology 53: 219–229.

101. SanchezDJ, GumperzJE, GanemD (2005) Regulation of CD1d expression and function by a herpesvirus infection. J Clin Invest 115: 1369–1378.

102. YuanW, DasguptaA, CresswellP (2006) Herpes simplex virus evades natural killer T cell recognition by suppressing CD1d recycling. Nat Immunol 7: 835–842.

103. RaoP, PhamHT, KulkarniA, YangY, LiuX, et al. (2011) Herpes simplex virus 1 glycoprotein B and US3 collaborate to inhibit CD1d antigen presentation and NKT cell function. J Virol 85: 8093–8104.

104. BosnjakL, SahlstromP, Paquin-ProulxD, LeeansyahE, MollM, et al. (2012) Contact-Dependent Interference with Invariant NKT Cell Activation by Herpes Simplex Virus-Infected Cells. J Immunol 188: 6216–6224.

105. Grubor-BaukB, SimmonsA, MayrhoferG, SpeckPG (2003) Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR. J Immunol 170: 1430–1434.

106. Grubor-BaukB, ArthurJL, MayrhoferG (2008) Importance of NKT cells in resistance to herpes simplex virus, fate of virus-infected neurons, and level of latency in mice. J Virol 82: 11073–11083.

107. CornishAL, KeatingR, KyparissoudisK, SmythMJ, CarboneFR, et al. (2006) NKT cells are not critical for HSV-1 disease resolution. Immunol Cell Biol 84: 13–19.

108. KulkarniRR, HaeryfarSM, SharifS (2010) The invariant NKT cell subset in anti-viral defenses: a dark horse in anti-influenza immunity? Journal of leukocyte biology 88: 635–643.

109. AshkarAA, RosenthalKL (2003) Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J Virol 77: 10168–10171.

110. De SantoC, SalioM, MasriSH, LeeLY, DongT, et al. (2008) Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J Clin Invest 118: 4036–4048.

111. HoLP, DenneyL, LuhnK, TeohD, ClellandC, et al. (2008) Activation of invariant NKT cells enhances the innate immune response and improves the disease course in influenza A virus infection. Eur J Immunol 38: 1913–1922.

112. PagetC, IvanovS, FontaineJ, RennesonJ, BlancF, et al. (2012) Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damage. J Biol Chem 287: 8816–8829.

113. IshikawaH, TanakaK, KutsukakeE, FukuiT, SasakiH, et al. (2010) IFN-gamma production downstream of NKT cell activation in mice infected with influenza virus enhances the cytolytic activities of both NK cells and viral antigen-specific CD8+ T cells. Virology 407: 325–332.

114. BentonKA, MisplonJA, LoCY, BrutkiewiczRR, PrasadSA, et al. (2001) Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or gamma delta T cells. J Immunol 166: 7437–7445.

115. KokWL, DenneyL, BenamK, ColeS, ClellandC, et al. (2011) Pivotal Advance: Invariant NKT cells reduce accumulation of inflammatory monocytes in the lungs and decrease immune-pathology during severe influenza A virus infection. J Leukoc Biol 91: 357–368.

116. ChenWW, XieYX, ZhangYH, FengYQ, LiBA, et al. (2010) [Changes and analysis of peripheral white blood cells and lymphocyte subsets for patients with pandemic influenza A virus (H1N1) infection]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 24: 331–333.

117. KoSY, KoHJ, ChangWS, ParkSH, KweonMN, et al. (2005) alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor. J Immunol 175: 3309–3317.

118. YounHJ, KoSY, LeeKA, KoHJ, LeeYS, et al. (2007) A single intranasal immunization with inactivated influenza virus and alpha-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system. Vaccine 25: 5189–5198.

119. GuillonneauC, MinternJD, HubertFX, HurtAC, BesraGS, et al. (2009) Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity. Proc Natl Acad Sci U S A 106: 3330–3335.

120. ReillyEC, ThompsonEA, AspeslaghS, WandsJR, ElewautD, et al. (2012) Activated iNKT cells promote memory CD8(+) T cell differentiation during viral infection. PLoS ONE 7: e37991 doi:10.1371/journal.pone.0037991.

121. Kopecky-BrombergSA, FraserKA, PicaN, CarneroE, MoranTM, et al. (2009) Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine. Vaccine 27: 3766–3774.

122. KamijukuH, NagataY, JiangX, IchinoheT, TashiroT, et al. (2008) Mechanism of NKT cell activation by intranasal coadministration of alpha-galactosylceramide, which can induce cross-protection against influenza viruses. Mucosal Immunol 1: 208–218.

123. LeeYS, LeeKA, LeeJY, KangMH, SongYC, et al. (2011) An alpha-GalCer analogue with branched acyl chain enhances protective immune responses in a nasal influenza vaccine. Vaccine 29: 417–425.

124. CourtneyAN, ThapaP, SinghS, WishahyAM, ZhouD, et al. (2011) Intranasal but not intravenous delivery of the adjuvant alpha-galactosylceramide permits repeated stimulation of natural killer T cells in the lung. Eur J Immunol 41: 3312–3322.

125. WojnoJ, JukesJP, GhadbaneH, ShepherdD, BesraGS, et al. (2012) Amide Analogs of CD1d Agonists Modulate iNKT cell-Mediated Cytokine Production. ACS Chem Biol 7: 847–855.

126. KerzerhoJ, YuED, BarraCM, Alari-PahisaE, GirardiE, et al. (2012) Structural and functional characterization of a novel nonglycosidic type I NKT agonist with immunomodulatory properties. J Immunol 188: 2254–2265.

127. MiuraS, KawanaK, SchustDJ, FujiiT, YokoyamaT, et al. (2010) CD1d, a sentinel molecule bridging innate and adaptive immunity, is downregulated by the human papillomavirus (HPV) E5 protein: a possible mechanism for immune evasion by HPV. J Virol 84: 11614–11623.

128. St JohnAL, RathoreAP, YapH, NgML, MetcalfeDD, et al. (2011) Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance. Proc Natl Acad Sci U S A 108: 9190–9195.

129. RennesonJ, GuabirabaR, MailletI, MarquesRE, IvanovS, et al. (2011) A detrimental role for invariant natural killer T cells in the pathogenesis of experimental dengue virus infection. Am J Pathol 179: 1872–1883.

130. ExleyMA, TahirSM, ChengO, ShaulovA, JoyceR, et al. (2001) A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses. J Immunol 167: 5531–5534.

131. KronenbergM, GapinL (2002) The unconventional lifestyle of NKT cells. Nat Rev Immunol 2: 557–568.

132. KronenbergM (2005) Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol 23: 877–900.

133. GodfreyDI, StankovicS, BaxterAG (2010) Raising the NKT cell family. Nat Immunol 11: 197–206.

134. MoodyDB, ZajoncDM, WilsonIA (2005) Anatomy of CD1-lipid antigen complexes. Nat Rev Immunol 5: 387–399.

135. BaronJL, GardinerL, NishimuraS, ShinkaiK, LocksleyR, et al. (2002) Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 16: 583–594.